@article{37e352b05bef4d7a9fda19831384fbc9,
title = "Correction: Targeting the DIO3 enzyme using first-in-class inhibitors effectively suppresses tumor growth: a new paradigm in ovarian cancer treatment (Oncogene, (2021), 40, 44, (6248-6257), 10.1038/s41388-021-02020-z)",
abstract = "In the original manuscript, there was an error in the name of one of the cell lines. Instead of OVCAR3 it should have been ES-2. This was amended in the published article and the supplementary material.",
author = "Dotan Moskovich and Yael Finkelshtein and Adi Alfandari and Amit Rosemarin and Tzuri Lifschytz and Avivit Weisz and Santanu Mondal and Harinarayana Ungati and Aviva Katzav and Debora Kidron and Govindasamy Mugesh and Martin Ellis and Bernard Lerer and Osnat Ashur-Fabian",
note = "Publisher Copyright: {\textcopyright} 2023 The Author(s), under exclusive licence to Springer Nature Limited.",
year = "2023",
month = may,
day = "2",
doi = "10.1038/s41388-023-02629-2",
language = "אנגלית",
volume = "42",
pages = "1508",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "18",
}